HealthEquity, Inc. (NASDAQ:HQY) Holdings Lifted by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC increased its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 19.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,420 shares of the company’s stock after acquiring an additional 566 shares during the period. Nisa Investment Advisors LLC’s holdings in HealthEquity were worth $280,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HQY. Norden Group LLC bought a new position in shares of HealthEquity in the first quarter valued at $391,000. BNP Paribas Financial Markets lifted its holdings in shares of HealthEquity by 15.3% during the first quarter. BNP Paribas Financial Markets now owns 49,286 shares of the company’s stock valued at $4,023,000 after purchasing an additional 6,536 shares during the last quarter. Janney Montgomery Scott LLC boosted its position in shares of HealthEquity by 27.4% in the 1st quarter. Janney Montgomery Scott LLC now owns 3,970 shares of the company’s stock valued at $324,000 after purchasing an additional 855 shares during the period. Fidelis Capital Partners LLC acquired a new position in shares of HealthEquity in the 1st quarter valued at $42,000. Finally, Texas Permanent School Fund Corp increased its stake in HealthEquity by 1.5% in the 1st quarter. Texas Permanent School Fund Corp now owns 75,092 shares of the company’s stock worth $6,130,000 after purchasing an additional 1,121 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts have commented on HQY shares. Barrington Research reaffirmed an “outperform” rating and set a $105.00 price objective on shares of HealthEquity in a research note on Friday, September 20th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $92.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. JMP Securities reiterated a “market outperform” rating and set a $105.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Bank of America reduced their target price on HealthEquity from $105.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, September 4th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $103.83.

HealthEquity Stock Up 9.8 %

HQY opened at $97.95 on Thursday. The company has a market capitalization of $8.55 billion, a PE ratio of 81.63, a price-to-earnings-growth ratio of 1.36 and a beta of 0.52. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. HealthEquity, Inc. has a fifty-two week low of $62.10 and a fifty-two week high of $99.00. The business has a 50-day moving average of $82.36 and a 200-day moving average of $80.19.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.16. The firm had revenue of $299.93 million for the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. Equities research analysts forecast that HealthEquity, Inc. will post 2.27 EPS for the current fiscal year.

Insider Activity at HealthEquity

In other news, Director Robert W. Selander sold 8,250 shares of the stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the transaction, the director now owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other HealthEquity news, Director Frank Corvino sold 1,247 shares of the business’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the transaction, the director now owns 4,823 shares of the company’s stock, valued at $387,093.98. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the sale, the director now directly owns 54,719 shares in the company, valued at approximately $4,540,582.62. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.